Deep Longevity

Deep Longevity is a biotech company that provides AI systems to track the rate of aging.

Deep Longevity has developed a longevity-as-a-service (LaaS) solution to integrate multiple, deep biomarkers of aging dubbed “aging clocks” to measure biological age. The aging clocks can reportedly predict biological and psychological age by analyzing various real-time data types like clinical blood reports, psychological surveys, microbiomic reports etc. using its patented technology. Its automated system of generating reports is available for clients where users can access detailed information on current biological age and get personalized, tangible health recommendations.

Its aging clocks include Blood Age, which provides clinical blood reports with a range of biomarkers (up to 45) and blood age predictions with a personalized summary report, Mind Age, a psychological questionnaire to predict mind age, well-being profile, and future wellbeing scores and give recommendations to improve wellbeing. It also offers 1) Microbiome Ag, a gut health profile reportedly revealed through data from Illumina NovaSeq6000-paired 300 bp reads with at least seven million read sequencing depth and 2) DeepM Age, an epigenetic aging clock with a 2.77 years error margin. The clock is claimed to show associations with cancer, dementia, obesity, and other age-related conditions. SenoClock is Deep Longevity’s SaaS platform that hosts all its aging clocks.

The company offers its products to a range of organizations, including insurers, employers, diagnostic solution providers, government, public, and consumer health organisations.